Evidence map›Paper›PMID 38027139›Full record

ArticleFrontiers in endocrinology2023

Case Report: A combination of chimeric

Jialin Li, Fenglan Zhang, Miao Xu, Hao Qiu, Cheng Zhou, Li Li, Lan Qin

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Adrenal causes of endocrine hypertension in childhood or adolescence.Journal of endocrinological investigation · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jialin Li *Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Fenglan Zhang *Clincal Genomics Center, Dian Diagnostics Group Co., Ltd., Hangzhou, China.
Miao XuDepartment of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Hao QiuClincal Genomics Center, Dian Diagnostics Group Co., Ltd., Hangzhou, China.
Cheng ZhouDepartment of Urology, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Li LiDepartment of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Lan QinClincal Genomics Center, Dian Diagnostics Group Co., Ltd., Hangzhou, China.
Dian Diagnostics (China) · CNNingbo University Affiliated Hospital · CNNingbo First Hospital · CNNingbo University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: 11β-Hydroxylase deficiency (11β-OHD, OMIM#202010) is the second most common form of congenital adrenal hyperplasia (CAH) caused by pathogenic variants in the Case presentation: We presented a suspected 11β-OHD female patient with incomplete virilization, adrenal hyperplasia, and hypokalemia hypertension. Whole exome sequencing (WES) revealed that the patient carried both a chimeric Conclusion: This report showed a rare

Indexed as

Adrenal Hyperplasia, CongenitalSteroid 11-beta-HydroxylaseCytochrome P-450 CYP11B2East Asian PeopleFemaleHumansMixed Function OxygenasesCytochrome P-450 CYP11B2Mixed Function OxygenasesSteroid 11-beta-Hydroxylase11β-hydroxylase deficiencychimeric CYP11B2/CYP11B1missense variantmolecular diagnosiswhole exome sequencing

Identifiers

PMID38027139
PMCPMC10679387
OpenAlexW4388651332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.